<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - AZITHROMYCIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>AZITHROMYCIN</h1>

        <p><a href="../drugClass/PHP34517.html">MACROLIDES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#exceptionsToLegalCategory" data-toggle="tab">Exceptions to legal category</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of secondary case of invasive group A streptococcal infection in patients who are allergic to penicillin</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg once daily for 5 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;11 years</strong><br/>
                12 mg/kg once daily (max. per dose 500 mg) for 5 days.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 mg once daily for 5 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Respiratory-tract infections, otitis media, skin and soft-tissue infections</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg once daily for 3 days, alternatively initially 500 mg once daily for 1 day, then 250 mg once daily for 4 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;17 years</strong><br/>
                10 mg/kg once daily (max. per dose 500 mg) for 3 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;17 years (body-weight 15&#8211;25 kg)</strong><br/>
                200 mg once daily for 3 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;17 years (body-weight 26&#8211;35 kg)</strong><br/>
                300 mg once daily for 3 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;17 years (body-weight 36&#8211;45 kg)</strong><br/>
                400 mg once daily for 3 days.</li>
              <li class="dose child"><strong>For children 6 months&#8211;17 years (body-weight 46 kg and above)</strong><br/>
                500 mg once daily for 3 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Uncomplicated genital chlamydial infections</span>,
                <span class="indication">Non-gonococcal urethritis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g for 1 dose.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                1 g for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Uncomplicated gonorrhoea</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Lyme disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg daily for 7&#8211;10 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Mild to moderate typhoid due to multiple-antibacterial resistant organisms</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg daily for 7 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Community-acquired pneumonia, low to moderate severity</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg once daily for 3 days, alternatively initially 500 mg once daily for 1 day, then 250 mg once daily for 4 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Community-acquired pneumonia, high severity</span>,
            </h4>
            <p class="specificity"><span class="route">Initially by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 500 mg once daily for at least 2 days, then (by mouth) 500 mg once daily for a total duration of 7&#8211;10 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Antibacterial prophylaxis for insertion of intra-uterine device</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Trachomatous conjunctivitis caused by <ph outputclass="organism"> <i>Chlamydia trachomatis</i> </ph></span>,
                <span class="indication">Purulent bacterial conjunctivitis</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply twice daily for 3 days, review if no improvement after 3 days of treatment.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply twice daily for 3 days, review if no improvement after 3 days of treatment.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Manufacturers advise use only if adequate alternatives not available.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Manufacturers advise use only if adequate alternatives not available.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Manufacturers advise avoid in severe liver disease&#8211;no information available.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Manufacturers advise avoid in severe liver disease&#8211;no information available.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Use with caution if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>
            </section>
            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Use with caution if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> blurred vision, ocular burning, ocular discomfort, ocular pruritus, anorexia in adults, arthralgia in adults, disturbances in taste in adults, disturbances in vision in adults, dizziness in adults, dyspepsia in adults, flatulence in adults, headache in adults, malaise in adults, paraesthesia in adults, reversible hearing loss (sometimes with tinnitus) after long-term therapy in adults, anorexia in adults, anorexia in children, arthralgia in adults, arthralgia in children, disturbances in taste in adults, disturbances in taste in children, disturbances in vision in adults, disturbances in vision in children, dizziness in adults, dizziness in children, dyspepsia in adults, dyspepsia in children, flatulence in adults, flatulence in children, headache in adults, headache in children, malaise in adults, malaise in children, paraesthesia in adults, paraesthesia in children, reversible hearing loss (sometimes with tinnitus) after long-term therapy in adults, reversible hearing loss (sometimes with tinnitus) after long-term therapy in children,
              </p>
              <p>
                <strong>uncommon:</strong> conjunctival hyperaemia, eyelid eczema, eyelid erythema, eyelid oedema, keratitis, anxiety in adults, chest pain in adults, constipation in adults, gastritis in adults, hypoaesthesia in adults, leucopenia in adults, oedema in adults, photosensitivity in adults, sleep disturbances in adults, anxiety in adults, anxiety in children, chest pain in adults, chest pain in children, constipation in adults, constipation in children, gastritis in adults, gastritis in children, hypoaesthesia in adults, hypoaesthesia in children, leucopenia in adults, leucopenia in children, oedema in adults, oedema in children, photosensitivity in adults, photosensitivity in children, sleep disturbances in adults, sleep disturbances in children,
              </p>
              <p>
                <strong>rare:</strong> agitation in adults, agitation in adults, agitation in children,
              </p>
              <p>
                <strong>notKnown:</strong> acute renal failure in adults, convulsions in adults, haemolytic anaemia in adults, interstitial nephritis in adults, smell disturbances in adults, syncope in adults, thrombocytopenia in adults, tongue discoloration in adults, acute renal failure in adults, acute renal failure in children, convulsions in adults, convulsions in children, haemolytic anaemia in adults, haemolytic anaemia in children, interstitial nephritis in adults, interstitial nephritis in children, smell disturbances in adults, smell disturbances in children, syncope in adults, syncope in children, thrombocytopenia in adults, thrombocytopenia in children, tongue discoloration in adults, tongue discoloration in children,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (<i>Zedbac</i>
            <tm tmtype="reg"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p><p>Reconstitute 500&#8239;mg with 4.8&#8239;mL water for injections to produce a 100&#8239;mg/mL solution, then dilute 5&#8239;mL of solution with infusion fluid to a final concentration of 1 or 2&#8239;mg/mL; give the 1&#8239;mg/mL solution over 3 hours <i>or</i> give the 2&#8239;mg/mL solution over 1 hour.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Azithromycin for bacterial infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/azithromycin-bacterial-infections-0">www.medicinesforchildren.org.uk/azithromycin-bacterial-infections-0</xref>
            </p>
            </section>
      </section>






      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Not licensed for typhoid fever, Lyme disease, chronic <ph outputclass="organism">
            <i>Pseudomonas aeruginosa</i>
            </ph> infection in cystic fibrosis, or prophylaxis of group A streptococcal infection.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Oral azithromycin not licensed for trachoma which results from chronic infection with <ph outputclass="organism">
            <i>Chlamydia trachomatis</i>
            </ph>.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Not licensed for uncomplicated gonorrhoea, mild or moderate typhoid due to multiple-antibacterial-resistant organisms, Lyme disease, or prophylaxis of group A streptococcal infection.</p><p>Not licensed for community-acquired pneumonia (high severity) when oral treatment continues for more than 3 days.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <p>Flavours of oral liquid formulations may include cherry or banana.</p>
            </section>
      </section>






      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use</h3>
              <p>Azithromycin Capsules may be prescribed.</p>
            </section>
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use</h3>
              <p>Azithromycin Tablets may be prescribed.</p>
            </section>
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use</h3>
              <p>Azithromycin Oral Suspension 200&#8239;mg/5&#8239;mL may be prescribed.</p>
            </section>
      </section>

      <section class="tab-pane" id="exceptionsToLegalCategory">
        <h2>Exceptions to legal category</h2>

            <section class="exceptionsToLegalCategory">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use</h3>
              <p>Azithromycin tablets can be sold to the public for the treatment of confirmed, asymptomatic <ph outputclass="organism">
            <i>Chlamydia trachomatis</i>
            </ph> genital infection in those over 16 years of age, and for the epidemiological treatment of their sexual partners, subject to maximum single dose of 1&#8239;g, maximum daily dose 1&#8239;g, and a pack size of 1&#8239;g.</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of AZITHROMYCIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral suspension,

            <div id="PHP75658"><a href="../medicinalForm/PHP75658.html" data-target="#PHP75658" data-action="load">Tablet</a></div>
            <div id="PHP75644"><a href="../medicinalForm/PHP75644.html" data-target="#PHP75644" data-action="load">Capsule</a></div>
            <div id="PHP75636"><a href="../medicinalForm/PHP75636.html" data-target="#PHP75636" data-action="load">Oral suspension</a></div>
            <div id="PHP75664"><a href="../medicinalForm/PHP75664.html" data-target="#PHP75664" data-action="load">Powder for solution for infusion</a></div>
            <div id="PHP75673"><a href="../medicinalForm/PHP75673.html" data-target="#PHP75673" data-action="load">Eye drops</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
